Drug Screening Market to Worth $11.6 Billion by 2026

Drug Screening Market to Worth $11.6 Billion by 2026 | Industry to Rise at CAGR 16.8%: MarketsandMarkets Analysis

Posted 2023-05-11 12:50:53

Drug screening is an important part of the healthcare industry, as it is a key factor in preventing health risks and ensuring the safety of the public. With the increasing prevalence of drug abuse and drug-related crimes, drug screening is becoming an increasingly important part of healthcare. The global drug screening market is estimated to reach USD 11.6 billion by 2026, growing at a compound annual growth rate of 16.8%.

The growth of the drug screening market is attributed to a number of factors. Firstly, the increasing prevalence of drug abuse and drug-related crimes is driving the demand for drug screening products. Furthermore, the increasing number of stringent government regulations and policies related to drug use is also driving the market growth. Moreover, the rising awareness of the health risks associated with drug abuse is also contributing to the growth of the drug screening market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

Key Market Players

The drug screening market is highly competitive with the presence of several small and big players. Some of the players offering products for drug screening market include Abbott Laboratories (US), Thermo Fisher Scientific (US), Quest Diagnostics (US), Alfa Scientific Designs (US), Roche (Switzerland), OraSure Technologies (US), MPD Inc. (US), and Shimadzu (Japan). These companies are investing heavily in research and development to expand their product portfolios and gain a competitive edge in the market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773

The study categorizes the Drug screening market into the following segments and subsegments:

By Product and Service

Drug Screening Product
Analytical Instruments
Rapid Testing Devices
Oral Fluid Testing Devices
Consumables
Drug Screening Service

By Sample Type

Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Other Samples

By End User

Drug Testing Laboratories
Workplaces
Criminal Justice and Law Enforcement Agencies
Hospitals
Drug Treatment Centers
Individual Users
Pain Management Centers
Schools and Colleges

By Region

North America
Europe
Asia Pacific
Rest of the World

Recent Developments

Quest Diagnostics and Select Health of South Carolina entered into an agreement to expand Select Health’s laboratory network for its Medicaid and Medicare-Medicaid dual-eligible enrollees and to enhance access to diagnostics information services for members.
LabCorp Entered into a multi-year agreement with Infirmary Health (US) to offer laboratory testing services in the eastern Gulf Coast.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=162987773

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/drug-alcohol-screening-market.asp

Visit Our Web Site: https://www.marketsandmarkets.com

Content Source: https://www.marketsandmarkets.com/PressReleases/drug-alcohol-screening.asp